Ex-vivo Examination of Excisions of Skin Tumors by Confocal Optical Coherence Tomography (LC-OCT) With Integrated Dermoscopy and Comparison With Histology (DERMOCTAV)
NCT05340543 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2022-04-22
Summary
This project aims to validate ex vivo the use of the OCTAV® prototype integrating the "dermoscope" function before an in vivo application, by comparing images obtained by the OCTAV® prototype integrating the "dermoscope" function with the histological sections of a skin tumor excision corresponding to them exactly, at the same level.
Conditions
- Cutaneous Tumor
- Optical Coherence Tomography
- Basal Cell Carcinoma
- Squamous Cell Carcinoma
- Melanoma
Interventions
- PROCEDURE
-
Confocal optical coherence tomography - OCTAVE
An ex vivo examination of cutaneous resection with the OCTAV® prototype integrating the "dermoscope" function
Sponsors & Collaborators
-
European Clinical Trial Experts Network
collaborator OTHER -
Ramsay Générale de Santé
lead OTHER
Principal Investigators
-
DRE RAMSAYGDS · Ramsay Générale de Santé
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-16
- Primary Completion
- 2022-06-16
- Completion
- 2022-06-16
Countries
- France
Study Locations
More Related Trials
-
Utility of Digital Dermoscopy in the Skin Cancer Clinic
NCT03497455 ·Status: TERMINATED
-
MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma
NCT04216953 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma
NCT01781572 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients
NCT04362722 ·Status: RECRUITING ·Phase: PHASE2
-
Precision Medicine for L/GCMN and Melanoma 2
NCT06605443 ·Status: RECRUITING
-
Comparison of eBX and Mohs Surgery for Treatment of Early-stage Non-melanoma Skin Cancer a Matched Pair Cohort Study.
NCT03024866 ·Status: COMPLETED
-
Assessment of Safety and Efficacy of OPM-101 Combined With Anti-PD-1 in Patients With Advanced Melanoma Showing Resistance to Anti-PD-1
NCT07040436 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Tracing Dissemination of Melanoma Cells in Healthy Tissues
NCT02854124 ·Status: COMPLETED
-
Neoadjuvant L19IL2/L19TNF- Pivotal Study
NCT02938299 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Neoadjuvant Combination Immunotherapy for Stage III Melanoma
NCT03842943 ·Status: RECRUITING ·Phase: PHASE2
-
Post-market Multi-Center RETRO-Prospective Study to Assess Long-term Clinical Outcomes NMSC Patients Treated With eBx
NCT05257486 ·Status: COMPLETED
-
Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)
NCT03284424 ·Status: COMPLETED ·Phase: PHASE2
-
DermTech's Non-Invasive Pigmented Lesion Assay to Detect and Track Lesions for Suspected Melanoma and to Determine Outcomes for up to 2 Years
NCT04563949 ·Status: COMPLETED
-
Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors
NCT06046144 ·Status: COMPLETED
-
Multi-Wavelength and Coherence Confocal Reflectance Microscopy of Pigmented and Non-Pigmented Lesions on the Skin In-Vivo
NCT00574392 ·Status: COMPLETED
-
A Study of ONCOS-102 in Combination With Other Novel Immune-therapies in Advanced Treatment-resistant Melanoma Patients
NCT05561491 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Comparison of Skin Grafts Versus Local Flaps for Facial Skin Cancer From the Patient Perspective: A Feasibility Study
NCT04805905 ·Status: UNKNOWN
-
LGX818 in Combination With Agents (MEK162; BKM120; LEE011; BGJ398; INC280) in Advanced BRAF Melanoma
NCT01820364 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC
NCT03291002 ·Status: UNKNOWN ·Phase: PHASE1
-
Interest of Tumor Replicates in Avian Embryo to Model Therapeutic Effects of BRAFi/MEKi in BRAF Mutated Melanoma
NCT04039672 ·Status: COMPLETED ·Phase: NA
-
Domatinostat in Combination With Avelumab in Patients With Advanced Merkel Cell Carcinoma Progressing on Anti-PD-(L)1
NCT04393753 ·Status: COMPLETED ·Phase: PHASE2
-
Added Value of OCT for Diagnosing Recurrent BCC After Non-invasive Treatment
NCT05581342 ·Status: COMPLETED ·Phase: NA
-
Advanced Non-invasive Diagnostics for Early Cutaneous Tumor Diagnosis, Clinical-therapeutic and Economic Management
NCT04789421 ·Status: COMPLETED ·Phase: NA
-
Dermatoscopy Guided Resection for Skin Cancer
NCT06342297 ·Status: RECRUITING ·Phase: NA
-
Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma
NCT04417621 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2